Sidley Austin has advised Werewolf Therapeutics. Cooley has advised Ambros Therapeutics. Latham & Watkins has advised the placement agents. Werewolf Therapeutics, Inc. (NASDAQ: HOWL) and Ambros...
Werewolf and Ambros Therapeutics Announce All-Stock Merger and $150 Million Private Placement
Axsome Therapeutics Acquires Global Rights to Balipodect from Takeda
Sidley has advised Axsome Therapeutics. White & Case has advised Takeda Pharmaceutical Company Limited. Axsome Therapeutics, Inc. (Nasdaq: AXSM) has acquired exclusive global rights to TAK-063...
Simcere and Boehringer Ingelheim Enter €1.05 Billion Licensing and Collaboration Agreement for Preclinical IBD Treatment
Sidley has advised Simcere Pharmaceutical Group Ltd. on the deal. Simcere Pharmaceutical Group Ltd. has entered into a licensing and collaboration agreement with Boehringer Ingelheim valued...
GE HealthCare Announces $2.3 Billion Acquisition of Intelerad
Sidley Austin LLP has advised GE HealthCare. Skadden, Arps, Slate, Meagher & Flom LLP has advised Intelerad. GE HealthCare has entered into an agreement to acquire...